Martek Biosciences---- future biotech cash cow! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Asymmetric who wrote (26)	3/25/1996 9:41:00 AM
From: bill small	of 258

Peter, so you too spend your mornings at this boob tube!!! Sure the risk on Martek is high compared to say S&P 500. But I don't think it high compared to most emerging biotechs. I suggest you try for a price pullback to around $30. I am looking to acquire more at this price. My thoughts are the stock will react only to "progress type reports" from the company until about this summer. As more launches in Europe begin and US launches hit in the fall, the stock will gain more noterity to the public. A MAJOR TRIGGER that I am looking to is the release of a study report from Australia which has been going on for a few years. This report, if favorable, will conclude DHA is beneficial to infants when DHA supplements are taken by nursing women. This would lead to the much larger market I addressed a few posts ago so I think would be a quick booster. Martek says report will be released in several months so I am guessing summer/fall. Even if report negative though, it wont diminish market for formula sales. best...........Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next